FATE - Fate Therapeutics Selected for Four Presentations Highlighting its Off-the-Shelf CAR T-Cell Portfolio in Autoimmune Disease at ACR Convergence 2026
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.